Live Quote · NASDAQLGNDHealthcare· Biotechnology

Ligand Pharmaceuticals Incorporated

$286.85▼ 0.03%($-0.09)
MKT CAP $5.74BNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
69/100
▌ Solid
33
Valuation
85
Profitability
100
Growth
68
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LGND research report →

Analyst Price Target
$350.00+22.0% vs. today

Range $326 – $406

Analyst RatingBuy
13 Buy4 Hold1 Sell

Price Chart

+44.12% · this period
$322.75$252.20$181.65Nov 20May 26Nov 20
52-Week Range82% of range
Low
$106.30
Current
$286.85
High
$326.63